Diagnosis and management of heparin-induced thrombocytopenia
Yves Gruel, Emmanuel De Maistre, Claire Pouplard, François Mullier, Sophie Susen, Stéphanie Roullet, Normand Blais, Grégoire Le Gal, André Vincentelli, Dominique Lasne, Thomas Lecompte, Pierre Albaladejo, Anne Godier, P. Albaladejo, S. Belisle, Normand Blais, F. Bonhomme, Annie Borel‐Derlon, J.Y. Borg, J.-L. Bosson, Ariel Cohen, J.-P. Collet, Emmanuel de Maistre, David Faraoni, Pierre Fontana, D. Garrigue Huet, Anne Godiér, Y. Gruel, J. Guay, Jean-Baptiste Hardy, Y. Huet, Brigitte Ickx, Silvy Laporte, Dominique Lasne, J.H. Levy, J. Llau, Grégoire Le Gal, Thomas Lecompte, Sarah Lessire, Dan Longrois, Samia Madi‐Jebara, Emmanuel Marret, J.‐L. Mas, Mikaël Mazighi, Guilherme Pereira Corrêa Meyer, P. Mismetti, Pierre‐Emmanuel Morange, S. Motte, François Mullier, N. Nathan, Philippe Nguyên, Yves Ozier, Gilles Pernod, Nadia Rosencher, Stéphanie Roullet, P.-M. Roy, Charles Marc Samama, S. Schlumberger, Jean‐François Schved, Piérre Siè, A. Steib, Sophie Susen, Sophie Testa, Éric Van Belle, Philipp Linden, André Vincentelli, P. Zufferey
Abstract
Heparin-induced thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis and management of affected patients. In 2002, a conference of experts mobilised by the French Society of Anaesthesia and Intensive Care Medicine (Société française d’anesthésie et de réanimation [SFAR]) drafted recommendations for the management of HIT [...]